Skip to main content

Table 2 Median workup results of NGAL concentration (sNGA and uNGAL) after cisplatin chemotherapy in during treatment periods

From: RETRACTED ARTICLE: Investigations of renal function using the level of neutrophil gelatinase-associated lipocalin associated with single-dose of cisplatin during chemotherapy

Variables

Day 0

Day 1

Day5

Day9

Day13

Day17

Day21

Day25

Day29

P*

sNGAL level in treated group

65.12 ± 6.73

68.23 ± 12.29

76.71 ± 18.56

96.64 ± 22.81

115.07 ± 21.01

134.20 ± 5.71

146 ± 6.21

150 ± 19.54

306.21 ± 25.47

P = 0.024

sNGAL level in Control

62 ± 10.74

61.53 ± 4.67

68.78 ± 8.23

73.32 ± 10..71

70.45 ± 10.58

81 ± 20.10

73.76 ± 10.32

78.37 ± 18.43

74.53 ± 16.43

P = 0.701

uNGAL level in treated group

47.64 ± 3.25

49.58 ± 314.35

90.83 ± 32.41

106.92 ± 37.54

127.41 ± 16.83

129.27 ± 27.86

163 ± 42.46

185.85 ± 20.12

386 ± 62.54

P = 0.011

uNGAL level in Control

49 ± 6.47

48.72 ± 22.61

46 ± 1.73

50 ± 9.16

53 ± 9.82

47.23 ± 15.46

40.54 ± 7.43

52.26 ± 12.33

51.34 ± 14.53

P = 0.612

  1. Differences were considered significant when P <0.05
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us